Inventor · disambiguated record
Yubin Miao
Also filed as: MIAO YUBIN
12 granted patents·2 pending applications·44 citations·filing 2009–2019
89Inventor score
Top patents by PatentIndex Score
14 records- 0189US9180214B1Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancerMIAO YUBIN·Filed 2012·Granted Nov 10, 2015·10 cites·33 claims
- 0287US8986651B2Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameMIAO YUBIN·Filed 2010·Granted Mar 24, 2015·10 cites·22 claims
- 0387US8603435B2Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameMIAO YUBIN·Filed 2009·Granted Dec 10, 2013·11 cites·23 claims
- 0482US9463255B1Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targetingMIAO YUBIN·Filed 2012·Granted Oct 11, 2016·2 cites·30 claims
- 0579US10238758B2Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targetingSTC UNM·Filed 2016·Granted Mar 26, 2019·1 cites·19 claims
- 0679US10047135B2Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameSTC UNM·Filed 2015·Granted Aug 14, 2018·2 cites·32 claims
- 0777US10265425B2Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameSTC UNM·Filed 2016·Granted Apr 23, 2019·1 cites·26 claims
- 0877US9393330B2Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameMIAO YUBIN·Filed 2013·Granted Jul 19, 2016·2 cites·47 claims
- 0976US10464985B2Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameSTC UNM·Filed 2018·Granted Nov 5, 2019·1 cites·29 claims
- 1071US9493537B2Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameSTC UNM·Filed 2015·Granted Nov 15, 2016·1 cites·24 claims
- 1170US11160887B2Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameUNM RAINFOREST INNOVATIONS·Filed 2019·Granted Nov 2, 2021·0 cites·23 claims
- 1266US9005575B2Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameMIAO YUBIN·Filed 2010·Granted Apr 14, 2015·3 cites·52 claims
- 1366US2019160188A1Radiolabeled Alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Melanoma TargetingSTC UNM·Filed 2019·Application pending·0 cites
- 1464US2020123216A1Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to sameSTC UNM·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yubin Miao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →